- Supported exchanges /
- AU /
- PTX.AU
Prescient Therapeutics Ltd (PTX AU) stock market data APIs
Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-100, a first in class compound with the ability to block an cancer growth enzyme, thereby disrupting the oncogenic Ras pathway. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.
Prescient Therapeutics Ltd Financial Data Overview
| 0.039 | |
| 0.04 | |
| - | |
| 0.04 | |
| 0.039 | |
| 0.037-0.105 | |
| 32 213 K | |
| 805 M | |
| 3 712 K | |
| 1.186 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Prescient Therapeutics Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 3 712 K
- EBITDA -7 185 701
- Earnings Per Share -0.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Prescient Therapeutics Ltd Earnings via APIs
- Latest Release 2024-08-26
- EPS/Forecast NaN
Get Prescient Therapeutics Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
